Substance P in CSF of patients with chronic pain syndromes

[1]  F. Johansson,et al.  Personality traits in patients with idiopathic pain disorder , 1987, Acta psychiatrica Scandinavica.

[2]  B. Almay.  Clinical characteristics of patients with idiopathic pain syndromes. Depressive symptomatology and patient pain drawings , 1987, Pain.

[3]  L. Knorring,et al.  5-HIAA and HVA in CSF in patients with idiopathic pain disorders , 1987, Biological Psychiatry.

[4]  A. Carlsson.  Personality characteristics of patients with chronic pain in comparison with normal controls and depressed patients , 1986, Pain.

[5]  J. Nurnberger,et al.  CSF substance P immunoreactivity in affective disorders , 1985, Biological Psychiatry.

[6]  L. Terenius,et al.  Elevation of substance P-like peptides in the CSF of psychiatric patients. , 1984, Biological psychiatry.

[7]  M. Åsberg,et al.  CSF monoamine metabolites in melancholia , 1984, Acta psychiatrica Scandinavica.

[8]  R. Spitzer,et al.  Idiopathic Pain Disorder: A Critique of Pain‐Prone Disorder and a Proposal for a Revision of the DSM‐III Category Psychogenic Pain Disorder , 1982, The Journal of nervous and mental disease.

[9]  W. Jb,et al.  idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder. , 1982 .

[10]  P. Hartvig,et al.  Postoperative demand for analgesics in relation to individual levels of endorphins and substance P in cerebrospinal fluid , 1982, PAIN.

[11]  J. Nutt,et al.  Substance P in human cerebrospinal fluid , 1980, Neurology.

[12]  L. Terenius,et al.  Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes , 1978, Pain.

[13]  T. Hökfelt,et al.  Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system , 1978, Neuroscience.

[14]  A. Guidotti,et al.  Presence of substance P and GABA in separate striatonigral neurons , 1977, Brain Research.

[15]  M. Brownstein,et al.  On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra , 1977, Brain Research.

[16]  B. Sjölund,et al.  Increased cerebrospinal fluid levels of endorphins after electro-acupuncture. , 1977, Acta physiologica Scandinavica.

[17]  Robert Elde,et al.  Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P , 1977 .

[18]  M. Åsberg,et al.  5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.

[19]  L. Terenius,et al.  Changes in CSF endorphins and monoamine metabolites related to treatment with high frequency transcutaneous electrical nerve stimulation , 1985 .

[20]  L. Terenius,et al.  Long-term high frequency transcutaneous electrical nerve stimulation (hi-TNS) in chronic pain. Clinical response and effects on CSF-endorphins, monoamine metabolites, substance P-like immunoreactivity (SPLI) and pain measures. , 1985, Journal of psychosomatic research.

[21]  Y. Hosobuchi,et al.  Elevated cerebrospinal fluid substance P in arachnoiditis is reduced by systemic administration of morphine. , 1982, Advances in biochemical psychopharmacology.

[22]  L. Terenius.  Endorphins and Pain , 1980 .